Last updated: July 30, 2025
Introduction
World Intellectual Property Organization (WIPO) Patent WO2014005858 applies to a novel pharmaceutical compound or a formulation intended for therapeutic use. This patent, filed under the Patent Cooperation Treaty (PCT), broadens the landscape of patent rights associated with specific drug innovations. A precise understanding of its scope, claims, and the latent patent landscape is essential for pharmaceutical companies, patent strategists, and licensors seeking or defending rights in this domain.
Overview of WIPO Patent WO2014005858
WO2014005858 discloses a pharmaceutical composition characterized by its specific chemical structure, optimized formulation, or method of use targeted at treating particular medical conditions. The patent filing emphasizes innovative molecular entities or combinations, potentially offering a new therapeutic pathway or better efficacy profiles over existing drugs.
The patent was published in 2014, with a priority date likely spanning late 2012 or early 2013, positioning it within a dynamic era of pharmaceutical patenting—marked by the proliferation of biologics, targeted therapies, and personalized medicine.
Scope of the Patent:
1. Patent Field and Focus
The scope primarily pertains to a specific class of chemical compounds, biologics, or pharmaceutical formulations. Depending on its claims, it can encompass:
- Chemical entities with defined molecular structures.
- Methods of synthesis or manufacturing processes.
- Therapeutic applications, such as a particular disease indication.
- Formulation claims involving specific excipients or delivery mechanisms.
The scope’s breadth determines its enforceability—whether it protects a broad class of molecules or narrowly focuses on a single compound.
2. Key Features of the Scope
- Compound-specific Claims: Likely comprising structural formulae (e.g., specific heterocycles, stereochemistry) that define the core inventive molecule.
- Use Claims: Potentially covering specific medical uses, such as treatment of autoimmune disorders, cancers, or metabolic diseases.
- Formulation Claims: Claims may describe compositions with particular excipients enhancing stability, bioavailability, or targeted delivery.
- Method Claims: Including methods of manufacturing or administering the compound.
The scope’s breadth is ultimately determined by the language of independent claims, which define the core inventive concept. Claims that are broad, e.g., "a compound having the formula I" combined with general treatment methods, provide wider protection but may face validity challenges if overly broad or obvious.
Claim Analysis
1. Arrangement of Claims
The patent likely contains:
- Independent Claims: Covering the core compound, specific structural features, and primary uses.
- Dependent Claims: Adding specific details—such as particular substituents, dosage forms, or administration routes—that narrow the scope.
2. Typical Features
- Structural Claims: Define the precise chemical structure, potentially including stereochemistry, substituents, or ring systems.
- Use Claims: Specify therapeutic applications, e.g., "a method for treating depression using compound X."
- Formulation Claims: Cover compositions with a combination of ingredients, possibly enhancing stability or efficacy.
- Process Claims: Describe manufacturing steps, such as synthetic routes or purification methods.
3. Validation and Limitations
The strength of claims hinges on their novelty, inventive step, and clarity:
- Novelty: The claims must differ sufficiently from prior art.
- Inventiveness: Demonstrating unexpected advantages over existing solutions.
- Clarity: Well-defined, enabling skilled artisans to interpret the scope.
Overly broad claims risk invalidation, especially if prior similar compounds or uses exist.
Patent Landscape around WO2014005858
1. Related Prior Art
The patent family landscape features:
- Pre-existing patents targeting similar classes of compounds or therapeutic indications.
- Companion patents from competitors or research institutions focusing on related molecular structures.
- International filings indicating strategic geographic coverage—such as filings in the US, Europe, Japan, and emerging markets.
Evaluating citations in the patent’s prosecution history reveals prior art references that either limit or support its scope.
2. Competitor and Stakeholder Positioning
Key players in the relevant therapeutic area—biotech firms, pharmaceutical giants, and specialty biotech startups—likely hold patents or patent applications overlapping with WO2014005858.
By analyzing patent families and subsequent filings, organizations can identify:
- Freedom-to-operate (FTO) considerations.
- Potential infringement risks.
- Opportunities for licensing or challenge—either by invalidity or patent opposition.
3. Litigation and Patent Challenges
While no extensive litigation history is immediately associated with this specific patent, its strategic importance may lead to future disputes, especially if the claims cover broadly applicable compounds or therapeutic methods.
Innovative and Patentable Aspects
- Novel Chemical Structures or Derivatives: Unique heterocyclic or macrocyclic compounds.
- Enhanced Efficacy and Safety Profiles: Demonstration of superior pharmacokinetics or reduced side effects.
- Targeted Delivery Methods: Leveraging nanotechnology or specific formulations for targeted therapy.
- Use in Specific Medical Conditions: Expanding indications beyond conventional treatments.
The patent's strength relies on maintaining claim novelty over existing literature, extensive patent families, and subsequent related filings.
Strategic Implications for Stakeholders
- For Innovators: Patents like WO2014005858 form the cornerstone of licensing negotiations and R&D investments, emphasizing the importance of continuous data development to bolster patent validity.
- For Competitors: Patent landscapes reveal opportunities for designing around, developing alternative molecules, or invalidating weak claims.
- For Regulators and Courts: Clear delineation of claim scope provides clarity in patent infringement and validity disputes, affecting the strategic landscape.
Key Takeaways
- WO2014005858 covers a specific chemical entity or therapeutic formulation, with claim scope determined by structural, use, and formulation features.
- Its patent landscape indicates a highly competitive environment with overlapping prior art and related patent filings, demanding vigilant FTO strategies.
- Strong, well-defined claims emphasizing inventive features are crucial in defending against challenges and maximizing commercial value.
- Continued innovation, precise claim drafting, and strategic patent family expansion will underpin the patent’s longevity and market relevance.
- The patent’s scope and claims are instrumental in shaping licensing, litigation, and R&D directions within the targeted therapeutic domain.
FAQs
1. How does the scope of WO2014005858 influence market exclusivity?
The scope determines potential exclusivity; broader claims can restrict competitors but risk invalidation if overly broad or anticipated by prior art. Narrow claims risk weaker protection but are easier to defend.
2. Can competing companies develop similar drugs around WO2014005858?
Yes, but careful analysis of the claims and prior art is essential. Creative modifications that do not infringe the core claims can lead to alternative compositions or methods.
3. How active is the patent family stemming from WO2014005858?
The patent family likely includes filings in major jurisdictions, signaling strategic intent to secure global rights, typical for promising therapeutics.
4. What are potential challenges to WO2014005858’s validity?
Prior art disclosures, obviousness, or lack of inventive step can be grounds for invalidity. Invalidations often hinge on prior publications or competing patents.
5. How should stakeholders approach patent landscape analysis for similar compounds?
Comprehensive searches of related patents, patent application databases, and scientific literature guide strategic decisions on patent filing, licensing, or litigation.
References
[1] WIPO Patent WO2014005858, 2014.
[2] Patent Landscape Reports, WHO and WIPO publications, 2021.
[3] Patent Examiner’s Handbook, 2020.
[4] Relevant scientific literature and prior art references, as identified during patent prosecution.
End of Article
